Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
FDA fast-tracks Boehringer's NSCLC drug review
The FDA has granted priority review to zongertinib for non-small cell lung cancer (NSCLC).
19 Feb 2025
OCEAN(a)-DOSE Trial: New Data on Lipoprotein(a) and Oxidised Phospholipids
Olpasiran significantly lowers oxidized phospholipids on apolipoprotein B but has no impact on systemic inflammatory markers in cardiovascular disease.
19 Feb 2025
New Study Explores ctDNA in Urothelial Cancer Treatment
Researchers aimed to establish a plasma ctDNA sequencing assay and evaluate its effectiveness in assessing tumour genetics and treatment response.
19 Feb 2025
Optimising Patient Outcomes in Advanced Gastrointestinal Stromal Tumours (GIST) in Europe
The European Society for Medical Oncology (ESMO) guidelines recommend life-long systemic tyrosine kinase inhibitor (TKI) therapies for…
19 Feb 2025
Twice-Yearly HIV Prevention Shot Nears FDA Decision
The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for the first-ever twice-yearly injectable HIV prevention therapy.
19 Feb 2025
Rezivertinib Outperforms Gefitinib in NSCLC Treatment Study
A Phase III trial has shown that rezivertinib offers superior progression-free survival compared to gefitinib as a first-line treatment in EGFR-mutated locally advanced or metastatic non-small-cell lung cancer.
19 Feb 2025
Combined Ultrasound Technique Reliable for Ruling Out N2 Disease in Patients with Lung Cancer
Study shows combined endobronchial ultrasound and endoscopic ultrasound (CUS) is a highly reliable tool for ruling out N2 disease in patients with PET-negative lung cancer.
7
Mins
19 Feb 2025
Azithromycin Susceptibility of Oral Streptococci in Men Who Have Sex With Men
A recent randomised controlled trial came to the surprising conclusion that dual gonococcal treatment with azithromycin/ceftriaxone…
19 Feb 2025
Self-Healing E-Skin Recovers in 10 Seconds, Transforming Biometric Wearables
A new self-healing E-Skin recovers within 10 seconds, enabling AI-assisted real-time health monitoring in extreme conditions.
19 Feb 2025
Onc Now: Episode 11: The Obesity Cancer Connection
Donal Brennan shares insights on ovarian cancer surgery, obesity-related carcinogenesis, and innovations in patient care.
←
1
2
3
…
20
21
22
23
24
25
26
…
1,058
1,059
1,060
→